MR imaging of salivary duct carcinoma

被引:0
|
作者
Motoori, K
Iida, U
Nagai, Y
Yamamoto, S
Ueda, T
Funatsu, H
Ito, H
Yoshitaka, O
机构
[1] Chiba Univ Hosp, Dept Radiol, Chuo Ku, Chiba, Japan
[2] Chiba Univ Hosp, Dept Otolaryngol, Chiba, Japan
[3] Chiba Postgrad Sch Med, Dept Mol Pathol, Sch Med, Chiba, Japan
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Salivary duct carcinoma (SDC) is regarded as a high-grade malignancy in the current classification of salivary gland neoplasms. The aim of our study was to describe the MR imaging features of SDC. METHODS: Nine patients with SDC underwent MR imaging study. The apparent diffusion coefficient (ADC) values of SDCs were measured from diffusion-weighted images. Time-signal intensity curves (TICs) of the tumors on dynamic MR images were plotted, and washout ratios were also calculated. TICs were divided into four types: type A, curve peaks < 120 seconds after administration of contrast material with high washout ratio (>= 30%); type B, curve peaks < 120 seconds with low washout ratio (< 30%); type C, curve peaks > 120 seconds; type D, nonenhanced. We correlated the MR findings of SDC with the pathologic findings. RESULTS. All tumors had ill-defined margins and showed low to moderately high signal intensity for contralateral parotid gland on T2-weighted images. The average of the ADC values of the SDCs was 1.16 +/- 0.14 [SD] X 10(-3)mm(2)/s. Seven of nine (78%) tumors had type B enhancement. On the other hand, six of nine (67%) tumors with rich fibrotic tissue also had type C enhancement. CONCLUSION. The findings of ill-defined margin, early enhancement with low washout ratio (type B), and low ADC value (1.22 X 10(-3)mm(2)/s) were useful for suggesting malignant salivary gland tumors. Although it was reported that type C enhancement was specific for pleomorphic adenoma, SDC frequently has type C-enhanced focus.
引用
收藏
页码:1201 / 1206
页数:6
相关论文
共 50 条
  • [1] SALIVARY DUCT CARCINOMA
    DELGADO, R
    VUITCH, F
    ALBORESSAAVEDRA, J
    CANCER, 1993, 72 (05) : 1503 - 1512
  • [2] SALIVARY DUCT CARCINOMA
    MURRAH, VA
    BATSAKIS, JG
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1994, 103 (03): : 244 - 247
  • [3] SALIVARY DUCT CARCINOMA
    GRENKO, RT
    GEMRYD, P
    TYTOR, M
    LUNDQVIST, PG
    BOERYD, B
    HISTOPATHOLOGY, 1995, 26 (03) : 261 - 266
  • [4] Salivary duct carcinoma
    D'heygere, Emmanuel
    Meulemans, Jeroen
    Poorten, Vincent Vander
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2018, 26 (02): : 142 - 151
  • [5] SALIVARY DUCT CARCINOMA
    KUMAR, RV
    KINI, L
    BHARGAVA, AK
    MUKHERJEE, G
    HAZARIKA, D
    SHENOY, AM
    ANANTHA, N
    JOURNAL OF SURGICAL ONCOLOGY, 1993, 54 (03) : 193 - 198
  • [6] Salivary duct carcinoma
    Thompson, Lester D. R.
    ENT-EAR NOSE & THROAT JOURNAL, 2012, 91 (09) : 356 - +
  • [7] Salivary duct carcinoma
    Hosal, AS
    Fan, CY
    Barnes, L
    Myers, EN
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2003, 129 (06) : 720 - 725
  • [8] SALIVARY DUCT CARCINOMA
    GARLAND, TA
    INNES, DJ
    FECHNER, RE
    LABORATORY INVESTIGATION, 1983, 48 (01) : A28 - A28
  • [9] Salivary duct carcinoma
    Hungermann, D
    Roeser, K
    Buerger, H
    Jäkel, T
    Löning, T
    Herbst, H
    PATHOLOGE, 2005, 26 (05): : 353 - 358
  • [10] Salivary duct carcinoma
    Ceylan, S.
    Yucel, Z.
    Huq, G. Erdem
    Bora, F.
    TURKISH ARCHIVES OF OTORHINOLARYNGOLOGY, 2008, 46 (04) : 325 - 328